Obtaining market authorization for Bleomycin from MHRA is a momentous accomplishment for Venus Pharma GmbH. Venus Remedies holds a total of 15 Market Authorizations (MA) for Bleomycin products across the globe. Venus Remedies is thrilled to announce the achievement of market authorization in the United Kingdom
The first international sale of the SSi Mantra was delivered to Dubai, United Arab Emirates Additional International Sales Expected SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), developer of the “SSi Mantra,” a versatile and cost-effective surgical robotic system, today announced that it
One-Stop Facility with cGMP Manufacturing to Bolster AMEA’s Biopharma Industry Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies, and applied materials industries, today inaugurated its expanded Singapore Hub which includes newly added cGMP manufacturing
Dr. Azad Moopen, Founder Chairman and MD of Aster DM, attends CEO Roundtable Session and Co-chairs session on the Continuum of Integrated Healthcare Aster’s MVT Unit Serves More Than 4000 international patients from Middle East, East and West Africa and SAARC countries Aster
Focuses on increased AI technology and client wins in Asia, Middle East The Telerad Group, a leading global provider of remote radiology services today announced a significant growth outlook of 50% for the upcoming financial year aiming to continue the momentum from last year’s (2022-23) 40%
Marking a major step in the global expansion strategy of Venus Remedies through its oncology products, this marketing authorisation from the largest GCC market will enable Venus Remedies to establish a strong foothold in GCC and MENA regions In a decisive step towards making its
AstraZeneca Pharma India Ltd. (AstraZeneca India), a leading biopharmaceutical company, announced the appointment of Bhavana Agrawal as Chief Finance Officer (CFO) with effect from October 1, 2023, following a transition period. She succeeds Rajesh Marwaha, who is retiring as CFO and full-time director of the
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans Venus Remedies Limited, a leading research-based pharmaceutical company, has achieved another significant milestone by securing a Good Manufacturing Practices (GMP) certification from
The company moves a step closer towards achieving its goal of emerging as the top oncology medicine supplier from India in the ASEAN region with the product registration from Philippines for bleomycin, a widely used cancer drug Venus Remedies also expects the marketing authorisation
Rezo.ai is virtually assisting over 10 million patients while cutting down the service provider’s operational costs by 20-30% New Delhi, November XX, 2021: Rezo.ai, India’s fastest evolving AI-powered contact center, is assisting one of India’s largest diagnostic and healthcare service providers with contact center automation.
